Skip to main content
SpringerLink
Log in

Adefovir dipivoxil/lamivudine/entecavir

Virological breakthrough and development of genotypic resistance: 18 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ze E, et al. Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir. Clinical and Molecular Hepatology 20: 267-73, No. 3, Sep 2014 - South Korea

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adefovir dipivoxil/lamivudine/entecavir. Reactions Weekly 1568, 20 (2015). https://doi.org/10.1007/s40278-015-5078-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-5078-5

Search

Navigation